Population-based assessment of re-treatment and healthcare utilisation after photoselective vaporisation of the prostate or electrosurgical transurethral resection of the prostate-Reference-Cited by-同舟云学术

Population-based assessment of re-treatment and healthcare utilisation after photoselective vaporisation of the prostate or electrosurgical transurethral resection of the prostate

Published:2019-08-26 Issue:6 Volume:124 Page:1047-1054
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Welk Blayne¹²³^ORCID,Reid Jennifer³,Ordon Michael³⁴^ORCID,Razvi Hassan¹,Campbell Jeffrey¹

Affiliation:

1. Department of Surgery; Western University; London ON Canada

2. Department of Epidemiology and Biostatistics; Western University; London ON Canada

3. Institute for Clinical Evaluative Sciences; London ON Canada

4. Department of Surgery; University of Toronto; London ON Canada

Funder

St Joseph's Hospital Foundation

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14891/fullpdf

Reference28 articles.

1. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline;Foster;J Urol,2018

2. The enlarged prostate: a brief history of its surgical treatment;Herr;BJU Int,2006

3. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia;Wasson;N Engl J Med,1995

4. A review of laser treatment for symptomatic BPH (benign prostatic hyperplasia);Nair;Curr Urol Rep,2016

5. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update;Cornu;Eur Urol,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enucleation of the prostate as retreatment for recurrent or residual benign prostatic obstruction: a systematic review and a meta-analysis;Prostate Cancer and Prostatic Diseases;2023-05-16

2. WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates;Urology;2022-07

3. Immediate Transurethral Plasma Kinetic Enucleation of the Prostate Gland for Treatment of Benign Prostatic Hyperplasia-Associated Massive Hemorrhage: A Single-Center Experience;Frontiers in Surgery;2022-01-12

4. Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results;BJUI Compass;2021-10-28

5. High regional variation in prostate surgery for benign prostatic hyperplasia in Switzerland;PLOS ONE;2021-07-22